On the public citation graph

Cyclometalated Ir( iii ) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy

0 signed · 162 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/anie.201000682openalex-snapshot
Iridium Complex with Antiangiogenic Properties
inferredcites →https://doi.org/10.1002/anie.201107333openalex-snapshot
[(Cp‐R)M(CO)3] (M=Re or 99mTc) Arylsulfonamide, Arylsulfamide, and Arylsulfamate Conjugates for Selective Targeting of Human Carbonic Anhydrase IX
inferredcites →https://doi.org/10.1002/anie.201307505openalex-snapshot
De Novo Generation of Singlet Oxygen and Ammine Ligands by Photoactivation of a Platinum Anticancer Complex
inferredcites →https://doi.org/10.1002/anie.201311161openalex-snapshot
The Potent Oxidant Anticancer Activity of Organoiridium Catalysts
inferredcites →https://doi.org/10.1002/anie.201400533openalex-snapshot
Visible‐Light‐Induced Annihilation of Tumor Cells with Platinum–Porphyrin Conjugates
inferredcites →https://doi.org/10.1002/chem.201300814openalex-snapshot
Histone‐Deacetylase‐Targeted Fluorescent Ruthenium(II) Polypyridyl Complexes as Potent Anticancer Agents
inferredcites →https://doi.org/10.1002/cmdc.201300060openalex-snapshot
Rhenium Complexes with Visible‐Light‐Induced Anticancer Activity
inferredcites →https://doi.org/10.1016/j.biomaterials.2013.06.028openalex-snapshot
Mitochondria-targeting cyclometalated iridium(III)–PEG complexes with tunable photodynamic activity
inferredcites →https://doi.org/10.1016/j.ccr.2013.01.034openalex-snapshot
Bioactive iridium and rhodium complexes as therapeutic agents
inferredcites →https://doi.org/10.1021/cr900300popenalex-snapshot
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
inferredcites →https://doi.org/10.1021/ja00099a026openalex-snapshot
Tetranuclear Bimetallic Complexes of Ruthenium, Osmium, Rhodium, and Iridium. Synthesis, Absorption Spectra, Luminescence, and Electrochemical Properties
inferredcites →https://doi.org/10.1021/ja1112996openalex-snapshot
Structurally Sophisticated Octahedral Metal Complexes as Highly Selective Protein Kinase Inhibitors
inferredcites →https://doi.org/10.1021/ja204997copenalex-snapshot
Phosphorescent Sensor for Robust Quantification of Copper(II) Ion
inferredcites →https://doi.org/10.1021/ja3009677openalex-snapshot
Strained Ruthenium Complexes Are Potent Light-Activated Anticancer Agents
inferredcites →https://doi.org/10.1021/ja401350xopenalex-snapshot
Gemcitabine–Coumarin–Biotin Conjugates: A Target Specific Theranostic Anticancer Prodrug
inferredcites →https://doi.org/10.1021/ja4045604openalex-snapshot
Cellular Toxicity Induced by the Photorelease of a Caged Bioactive Molecule: Design of a Potential Dual-Action Ru(II) Complex
inferredcites →https://doi.org/10.1021/ja408426zopenalex-snapshot
Exploitation of Long-Lived 3IL Excited States for Metal–Organic Photodynamic Therapy: Verification in a Metastatic Melanoma Model
inferredcites →https://doi.org/10.1021/ml100295vopenalex-snapshot
Synthesis and Biological Evaluation of JAHAs: Ferrocene-Based Histone Deacetylase Inhibitors
inferredcites →https://doi.org/10.1021/ol102562kopenalex-snapshot
Tuning Photosensitized Singlet Oxygen Generation Efficiency of Novel Aza-BODIPY Dyes
inferredcites →https://doi.org/10.1038/nbt1272openalex-snapshot
Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug
inferredcites →https://doi.org/10.1038/nrc1071openalex-snapshot
Photodynamic therapy for cancer
inferredcites →https://doi.org/10.1038/nrc1779openalex-snapshot
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
inferredcites →https://doi.org/10.1038/onc.2008.297openalex-snapshot
Caspases in apoptosis and beyond
inferredcites →https://doi.org/10.1038/onc.2011.384openalex-snapshot
Molecular mechanisms of cisplatin resistance
inferredcites →https://doi.org/10.1039/b108586gopenalex-snapshot
The role of apoptosis in response to photodynamic therapy: what, where, why, and how
inferredcites →https://doi.org/10.1039/c1cc15378aopenalex-snapshot
Dual anticancer activity in a single compound: visible-light-induced apoptosis by an antiangiogenic iridium complex
inferredcites →https://doi.org/10.1039/c1md00203aopenalex-snapshot
Click JAHAs: conformationally restricted ferrocene-based histone deacetylase inhibitors
inferredcites →https://doi.org/10.1039/c2cc36907aopenalex-snapshot
Cyclometalated iridium( iii ) polypyridine dibenzocyclooctyne complexes as the first phosphorescent bioorthogonal probes
inferredcites →https://doi.org/10.1039/c2cs35171dopenalex-snapshot
Photofunctional triplet excited states of cyclometalated Ir(iii) complexes: beyond electroluminescence
inferredcites →https://doi.org/10.1039/c3dt51817eopenalex-snapshot
Towards cancer cell-specific phototoxic organometallic rhenium( i ) complexes
inferredcites →https://doi.org/10.1039/c3dt51917aopenalex-snapshot
Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen–SAHA hybrids and related species
inferredcites →https://doi.org/10.1039/c3sc53550aopenalex-snapshot
Photo-induced uncaging of a specific Re( i ) organometallic complex in living cells
inferredcites →https://doi.org/10.1074/jbc.273.50.33533openalex-snapshot
Importance of Poly(ADP-ribose) Polymerase and Its Cleavage in Apoptosis
inferredcites →https://doi.org/10.1101/cshperspect.a018713openalex-snapshot
Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
inferredcites →https://doi.org/10.1128/mcb.00413-08openalex-snapshot
Histone Deacetylase Inhibitors Modify Pancreatic Cell Fate Determination and Amplify Endocrine Progenitors
inferredcites →https://doi.org/10.1146/annurev-genet-102108-134850openalex-snapshot
The Role of Mitochondria in Apoptosis
inferredcites →https://doi.org/10.1186/1476-4598-8-93openalex-snapshot
EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells
inferredcites →https://doi.org/10.3322/caac.20114openalex-snapshot
Photodynamic therapy of cancer: An update

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4725194openalex-extracted
A Meso-Protonated Iridium(Iii) Α-Octabutoxyphthalocyanine for Enhanced Near-Infrared Driven the Generation of Singlet Oxygen and Photothermal Property
inferred← citeshttps://doi.org/10.1002/9781119007166.ch9openalex-snapshot
Strategic Applications of Luminescent Iridium(III) Complexes as Biomolecular Probes, Cellular Imaging Reagents, and Photodynamic Therapeutics
inferred← citeshttps://doi.org/10.1002/ange.202014959openalex-snapshot
Ferroptosis Photoinduced by New Cyclometalated Iridium(III) Complexes and Its Synergism with Apoptosis in Tumor Cell Inhibition
inferred← citeshttps://doi.org/10.1002/ange.202114600openalex-snapshot
A Nuclear‐Targeted AIE Photosensitizer for Enzyme Inhibition and Photosensitization in Cancer Cell Ablation
inferred← citeshttps://doi.org/10.1002/anie.202014959openalex-snapshot
Ferroptosis Photoinduced by New Cyclometalated Iridium(III) Complexes and Its Synergism with Apoptosis in Tumor Cell Inhibition
inferred← citeshttps://doi.org/10.1002/anie.202114600openalex-snapshot
A Nuclear‐Targeted AIE Photosensitizer for Enzyme Inhibition and Photosensitization in Cancer Cell Ablation
inferred← citeshttps://doi.org/10.1002/aoc.4746openalex-snapshot
Lysosome‐targeted Cyclometalated Iridium (III) Anticancer Complexes Bearing Phosphine‐Sulfonate Ligands
inferred← citeshttps://doi.org/10.1002/aoc.6964openalex-snapshot
Phosphorescent cyclometalated iridium(III) complexes with mono‐, di‐, and tetranuclear as two channel probes to light up the nuclei of living cells
inferred← citeshttps://doi.org/10.1002/asia.201800103openalex-snapshot
Triphenylamine‐Appended Half‐Sandwich Iridium(III) Complexes and Their Biological Applications
inferred← citeshttps://doi.org/10.1002/cbic.201800507openalex-snapshot
Rational Design of Phosphorescent Iridium(III) Complexes for Selective Glutathione Sensing and Amplified Photodynamic Therapy
inferred← citeshttps://doi.org/10.1002/chem.201501675openalex-snapshot
Serum Albumin Binding Inhibits Nuclear Uptake of Luminescent Metal‐Complex‐Based DNA Imaging Probes
inferred← citeshttps://doi.org/10.1002/chem.201502154openalex-snapshot
Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells
inferred← citeshttps://doi.org/10.1002/chem.201505160openalex-snapshot
Mono‐ and Dinuclear Phosphorescent Rhenium(I) Complexes: Impact of Subcellular Localization on Anticancer Mechanisms
inferred← citeshttps://doi.org/10.1002/chem.201604792openalex-snapshot
Metal Complexes for Two‐Photon Photodynamic Therapy: A Cyclometallated Iridium Complex Induces Two‐Photon Photosensitization of Cancer Cells under Near‐IR Light
inferred← citeshttps://doi.org/10.1002/chem.201703157openalex-snapshot
Valproic Acid‐Functionalized Cyclometalated Iridium(III) Complexes as Mitochondria‐Targeting Anticancer Agents
inferred← citeshttps://doi.org/10.1002/chem.201705335openalex-snapshot
Heterobimetallic Complexes for Theranostic Applications
inferred← citeshttps://doi.org/10.1002/chem.201705561openalex-snapshot
Cancer‐Targeting Functionalization of Selenium‐Containing Ruthenium Conjugate with Tumor Microenvironment‐Responsive Property to Enhance Theranostic Effects
inferred← citeshttps://doi.org/10.1002/cmdc.202400649openalex-snapshot
Current Context of Designing Phototheranostic Cyclometalated Iridium (III) Complexes to Open a New Avenue in Cancer Therapy
inferred← citeshttps://doi.org/10.1002/cplu.201600413openalex-snapshot
Anticancer RuII and RhIII Piano‐Stool Complexes that are Histone Deacetylase Inhibitors
inferred← citeshttps://doi.org/10.1002/ejic.201601129openalex-snapshot
Cyclometalated IrIII Complexes as Mitochondria‐Targeted Photodynamic Anticancer Agents
inferred← citeshttps://doi.org/10.1002/smll.201501923openalex-snapshot
Nanocomposite‐Based Photodynamic Therapy Strategies for Deep Tumor Treatment
inferred← citeshttps://doi.org/10.1002/smll.202310342openalex-snapshot
Progress and Challenges in Tumor Ferroptosis Treatment Strategies: A Comprehensive Review of Metal Complexes and Nanomedicine
inferred← citeshttps://doi.org/10.1007/s00604-016-1917-1openalex-snapshot
Mitochondria-targeted theranostic nanoparticles for optical sensing of oxygen, photodynamic cancer therapy, and assessment of therapeutic efficacy
inferred← citeshttps://doi.org/10.1016/b978-0-08-101011-2.00007-6openalex-snapshot
Anticancer Hybrids
inferred← citeshttps://doi.org/10.1016/b978-0-08-102860-5.00002-xopenalex-snapshot
Thiophenes, benzannulated forms, and analogs
inferred← citeshttps://doi.org/10.1016/b978-0-12-409547-2.14249-0openalex-snapshot
Organometallics in Cancer Treatment—Non-conventional Structures and Modes of Action
inferred← citeshttps://doi.org/10.1016/b978-0-12-823144-9.00061-3openalex-snapshot
Phosphorescent metal complexes for biomedical applications
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2015.04.002openalex-snapshot
Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2018.08.065openalex-snapshot
Cancer-specific chemotherapeutic strategy based on the vitamin K3 mediated ROS regenerative feedback and visualized drug release in vivo
inferred← citeshttps://doi.org/10.1016/j.bioorg.2020.104396openalex-snapshot
Inhibition of histone deacetylases, topoisomerases and epidermal growth factor receptor by metal-based anticancer agents: Design & synthetic strategies and their medicinal attributes
inferred← citeshttps://doi.org/10.1016/j.ccr.2018.01.010openalex-snapshot
Cyclometalated iridium(III) luminescent complexes in therapy and phototherapy
inferred← citeshttps://doi.org/10.1016/j.ccr.2018.03.020openalex-snapshot
Transition metal complexes as photosensitisers in one- and two-photon photodynamic therapy
inferred← citeshttps://doi.org/10.1016/j.ccr.2018.11.013openalex-snapshot
Dual function luminescent transition metal complexes for cancer theranostics: The combination of diagnosis and therapy
inferred← citeshttps://doi.org/10.1016/j.ccr.2019.07.009openalex-snapshot
Perspectives of molecular and nanostructured systems with d- and f-block metals in photogeneration of reactive oxygen species for medical strategies
inferred← citeshttps://doi.org/10.1016/j.ccr.2020.213267openalex-snapshot
Recent advances of iridium(III) metallophosphors for health-related applications
inferred← citeshttps://doi.org/10.1016/j.ccr.2022.214860openalex-snapshot
Recent advances on organelle specific Ru(II)/Ir(III)/Re(I) based complexes for photodynamic therapy
inferred← citeshttps://doi.org/10.1016/j.ccr.2022.214899openalex-snapshot
Targeting emerging cancer hallmarks by transition metal complexes: Epigenetic reprogramming and epitherapies. Part II
inferred← citeshttps://doi.org/10.1016/j.ccr.2023.215462openalex-snapshot
Metallotherapeutic complexes with high selective properties for anti-neoplastic therapy
inferred← citeshttps://doi.org/10.1016/j.ccr.2023.215580openalex-snapshot
Advances of metallodrug-amyloid β aggregation inhibitors for therapeutic intervention in neurodegenerative diseases: Evaluation of their mechanistic insights and neurotoxicity
inferred← citeshttps://doi.org/10.1016/j.ccr.2024.216118openalex-snapshot
Revolutionizing anticancer treatment: Ruthenium-based nanoplatforms pave new paths
inferred← citeshttps://doi.org/10.1016/j.cej.2024.150345openalex-snapshot
Polyrotaxanated covalent organic frameworks based on β-cyclodextrin towards high-efficiency synergistic inactivation of bacterial pathogens
inferred← citeshttps://doi.org/10.1016/j.colsurfb.2020.110810openalex-snapshot
A novel versatile yolk-shell nanosystem based on NIR-elevated drug release and GSH depletion-enhanced Fenton-like reaction for synergistic cancer therapy
inferred← citeshttps://doi.org/10.1016/j.dyepig.2021.109886openalex-snapshot
Phosphorogenic dipyrrinato-iridium(III) complexes as photosensitizers for photodynamic therapy
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.06.045openalex-snapshot
Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.111751openalex-snapshot
Strong in vitro and vivo cytotoxicity of novel organoplatinum(II) complexes with quinoline-coumarin derivatives
inferred← citeshttps://doi.org/10.1016/j.ejmech.2021.113363openalex-snapshot
Novel dual-mode antitumor chlorin-based derivatives as potent photosensitizers and histone deacetylase inhibitors for photodynamic therapy and chemotherapy
inferred← citeshttps://doi.org/10.1016/j.ejmech.2022.114736openalex-snapshot
Novel zinc(II)−curcumin molecular probes bearing berberine and jatrorrhizine derivatives as potential mitochondria-targeting anti-neoplastic drugs
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.116648openalex-snapshot
Iridium(III) complexes as novel theranostic small molecules for medical diagnostics, precise imaging at a single cell level and targeted anticancer therapy
inferred← citeshttps://doi.org/10.1016/j.inoche.2020.108364openalex-snapshot
Drive to organoruthenium and organoiridium complexes from organoplatinum: Next-generation anticancer metallotherapeutics
inferred← citeshttps://doi.org/10.1016/j.jinorgbio.2019.110909openalex-snapshot
Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents
inferred← citeshttps://doi.org/10.1016/j.jinorgbio.2021.111354openalex-snapshot
Visible light-controlled carbon monoxide delivery combined with the inhibitory activity of histone deacetylases from a manganese complex for an enhanced antitumor therapy
inferred← citeshttps://doi.org/10.1016/j.jinorgbio.2021.111450openalex-snapshot
Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis
inferred← citeshttps://doi.org/10.1016/j.jinorgbio.2021.111656openalex-snapshot
NIR light-controlled mitochondria-targeted delivery of carbon monoxide combined with histone deacetylase inhibition for synergistic anticancer therapy
inferred← citeshttps://doi.org/10.1016/j.jinorgbio.2022.111790openalex-snapshot
Rational design of mitochondria targeted thiabendazole-based Ir(III) biscyclometalated complexes for a multimodal photodynamic therapy of cancer
inferred← citeshttps://doi.org/10.1016/j.jinorgbio.2022.112090openalex-snapshot
Heteronuclear Ru(II)-Re(I) complexes as potential photodynamic anticancer agents with anti-metastatic and anti-angiogenic activities
inferred← citeshttps://doi.org/10.1016/j.jorganchem.2017.03.038openalex-snapshot
Advances in the design of organometallic anticancer complexes
inferred← citeshttps://doi.org/10.1016/j.microc.2020.105721openalex-snapshot
Curcumin ligand based iridium(III) complexes as inhibition and visualization agent of beta-amyloid fibrillation
inferred← citeshttps://doi.org/10.1021/acs.chemrev.1c00381openalex-snapshot
Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy
inferred← citeshttps://doi.org/10.1021/acs.inorgchem.4c02633openalex-snapshot
Mixed Ru(II)–Ir(III) Complexes as Photoactive Inhibitors of the Major Human Drug Metabolizing Enzyme CYP3A4
inferred← citeshttps://doi.org/10.1021/acs.inorgchem.4c03950openalex-snapshot
Mitochondria Localized Anticancer Iridium(III) Prodrugs for Targeted Delivery of Myeloid Cell Leukemia-1 (Mcl-1) Inhibitors and Cytotoxic Iridium(III) Complex
inferred← citeshttps://doi.org/10.1021/acs.inorgchem.5b00369openalex-snapshot
Photochemical Properties of Red-Emitting Tris(cyclometalated) Iridium(III) Complexes Having Basic and Nitro Groups and Application to pH Sensing and Photoinduced Cell Death
inferred← citeshttps://doi.org/10.1021/acs.inorgchem.5b02872openalex-snapshot
Design and Synthesis of Heteroleptic Cyclometalated Iridium(III) Complexes Containing Quinoline-Type Ligands that Exhibit Dual Phosphorescence
inferred← citeshttps://doi.org/10.1021/acs.inorgchem.7b01693openalex-snapshot
Anticancer Activity of Iridium(III) Complexes Based on a Pyrazole-Appended Quinoline-Based BODIPY
inferred← citeshttps://doi.org/10.1021/acs.inorgchem.8b00789openalex-snapshot
Photophysical and Photobiological Properties of Dinuclear Iridium(III) Bis-tridentate Complexes
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.3c00189openalex-snapshot
Exploring Structure–Activity Relationships in Photodynamic Therapy Anticancer Agents Based on Ir(III)-COUPY Conjugates
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.4c00249openalex-snapshot
Construction of 5-Fluorouracil and Gallium Corrole Conjugates for Enhanced Photodynamic Therapy
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b00112openalex-snapshot
Identification of an Iridium(III)-Based Inhibitor of Tumor Necrosis Factor-α
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.0c00458openalex-snapshot
Delivery of Platinum(IV) Prodrugs via Bi2Te3 Nanoparticles for Photothermal–Chemotherapy and Photothermal/Photoacoustic Imaging
inferred← citeshttps://doi.org/10.1021/acs.organomet.7b00437openalex-snapshot
Pojamide: An HDAC3-Selective Ferrocene Analogue with Remarkably Enhanced Redox-Triggered Ferrocenium Activity in Cells
inferred← citeshttps://doi.org/10.1021/acsabm.2c00461openalex-snapshot
Chemo-photodynamic Activity of Silicon Phthalocyanines Bearing Cyclooxygenase Inhibitors on Colorectal Cancer Cell Lines
inferred← citeshttps://doi.org/10.1021/acsabm.5c00393openalex-snapshot
Monomer Versus Dimer of Cationic Ir(III) Complexes for Photodynamic Therapy by Two-Photon Activation: A Comparative Study
inferred← citeshttps://doi.org/10.1021/acsami.6b13808openalex-snapshot
Graphene Oxide Decorated with Ru(II)–Polyethylene Glycol Complex for Lysosome-Targeted Imaging and Photodynamic/Photothermal Therapy
inferred← citeshttps://doi.org/10.1021/acsami.7b01735openalex-snapshot
Light-Up Mitophagy in Live Cells with Dual-Functional Theranostic Phosphorescent Iridium(III) Complexes
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.9b01544openalex-snapshot
A Tumor Microenvironment Destroyer for Efficient Cancer Suppression
inferred← citeshttps://doi.org/10.1021/acsomega.0c03180openalex-snapshot
A Translational Study of a Silicon Phthalocyanine Substituted with a Histone Deacetylase Inhibitor for Photodynamic Therapy
inferred← citeshttps://doi.org/10.1021/acsomega.3c04867openalex-snapshot
Recent Advancement in the Synthesis of Ir-Based Complexes
inferred← citeshttps://doi.org/10.1021/ic502378zopenalex-snapshot
A Luminescent Poly(amidoamine)–Iridium Complex as a New Singlet-Oxygen Sensitizer for Photodynamic Therapy
inferred← citeshttps://doi.org/10.1038/srep38954openalex-snapshot
Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents
inferred← citeshttps://doi.org/10.1039/9781788016452-00031openalex-snapshot
Ruthenium, Osmium and Iridium in the Fight Against Cancer
inferred← citeshttps://doi.org/10.1039/c5cc02354hopenalex-snapshot
A phosphorescent rhenium( i ) histone deacetylase inhibitor: mitochondrial targeting and paraptosis induction
inferred← citeshttps://doi.org/10.1039/c5dt04275eopenalex-snapshot
Development of trackable metal-based drugs: new generation of therapeutic agents
inferred← citeshttps://doi.org/10.1039/c5sc01955aopenalex-snapshot
Cyclometalated iridium( iii ) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agents
inferred← citeshttps://doi.org/10.1039/c5tb01501dopenalex-snapshot
Selenadiazole derivatives as theranostic agents for simultaneous cancer chemo-/radiotherapy by targeting thioredoxin reductase
inferred← citeshttps://doi.org/10.1039/c5tb02555aopenalex-snapshot
Near-infrared triggered generation of reactive oxygen species from upconverting nanoparticles decorated with an organoiridium complex
inferred← citeshttps://doi.org/10.1039/c6dt00601aopenalex-snapshot
Coumarin-appended phosphorescent cyclometalated iridium( iii ) complexes as mitochondria-targeted theranostic anticancer agents
inferred← citeshttps://doi.org/10.1039/c6dt02416eopenalex-snapshot
Increasing the triplet lifetime and extending the ground-state absorption of biscyclometalated Ir( iii ) complexes for reverse saturable absorption and photodynamic therapy applications
inferred← citeshttps://doi.org/10.1039/c6sc02901aopenalex-snapshot
Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium( iii ) complexes
inferred← citeshttps://doi.org/10.1039/c7cs00195aopenalex-snapshot
The development of anticancer ruthenium( ii ) complexes: from single molecule compounds to nanomaterials
inferred← citeshttps://doi.org/10.1039/c7dt00913eopenalex-snapshot
Near-infrared-emitting heteroleptic cationic iridium complexes derived from 2,3-diphenylbenzo[g]quinoxaline as in vitro theranostic photodynamic therapy agents
inferred← citeshttps://doi.org/10.1039/c7dt01043eopenalex-snapshot
Fluorinated cyclometalated iridium( iii ) complexes as mitochondria-targeted theranostic anticancer agents
inferred← citeshttps://doi.org/10.1039/c7dt01091eopenalex-snapshot
The discovery of half-sandwich iridium complexes containing lidocaine and (pyren-1-yl)ethynyl derivatives of phenylcyanamide ligands for photodynamic therapy
inferred← citeshttps://doi.org/10.1039/c7dt02273eopenalex-snapshot
Mixed-ligand iridium( iii ) complexes as photodynamic anticancer agents
inferred← citeshttps://doi.org/10.1039/c7dt02477kopenalex-snapshot
Iridium( iii ) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy
inferred← citeshttps://doi.org/10.1039/c7nj02224gopenalex-snapshot
Preparation of metalated azine complexes of iridium( iii )
inferred← citeshttps://doi.org/10.1039/c7nr05349eopenalex-snapshot
Ruthenium complex-modified carbon nanodots for lysosome-targeted one- and two-photon imaging and photodynamic therapy
inferred← citeshttps://doi.org/10.1039/c8cc09396bopenalex-snapshot
A smart perylene derived photosensitizer for lysosome-targeted and self-assessed photodynamic therapy
inferred← citeshttps://doi.org/10.1039/c8dt00783gopenalex-snapshot
Cyclometalated iridium( iii ) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo
inferred← citeshttps://doi.org/10.1039/c8ra00265gopenalex-snapshot
Pyridazine-bridged cationic diiridium complexes as potential dual-mode bioimaging probes
inferred← citeshttps://doi.org/10.1039/c9dt04594eopenalex-snapshot
Complexes of oxoplatin with rhein and ferulic acid ligands as platinum( iv ) prodrugs with high anti-tumor activity
inferred← citeshttps://doi.org/10.1039/c9sc00696fopenalex-snapshot
Cyclometalated iridium–BODIPY ratiometric O 2 sensors
inferred← citeshttps://doi.org/10.1039/d0cc00524jopenalex-snapshot
Imaging and therapeutic applications of Zn( ii )-cryptolepine–curcumin molecular probes in cell apoptosis detection and photodynamic therapy
inferred← citeshttps://doi.org/10.1039/d0cs00173bopenalex-snapshot
Recent progress in photosensitizers for overcoming the challenges of photodynamic therapy: from molecular design to application
inferred← citeshttps://doi.org/10.1039/d0dt00180eopenalex-snapshot
Cyclometalated iridium( iii ) complexes for mitochondria-targeted combined chemo-photodynamic therapy
inferred← citeshttps://doi.org/10.1039/d0mt00060dopenalex-snapshot
Mitochondria-targeted artesunate conjugated cyclometalated iridium( iii ) complexes as potent anti-HepG2 hepatocellular carcinoma agents
inferred← citeshttps://doi.org/10.1039/d1ra05404jopenalex-snapshot
Evaluation of histone deacetylase inhibitor substituted zinc and indium phthalocyanines for chemo- and photodynamic therapy
inferred← citeshttps://doi.org/10.1039/d2dt00719copenalex-snapshot
Novel heterobimetallic Ir( iii )–Re( i ) complexes: design, synthesis and antitumor mechanism investigation
inferred← citeshttps://doi.org/10.1039/d2dt01765bopenalex-snapshot
8-Hydroxyquinoline-modified ruthenium( ii ) polypyridyl complexes for JMJD inhibition and photodynamic antitumor therapy
inferred← citeshttps://doi.org/10.1039/d2md00356bopenalex-snapshot
Therapeutic significance of molecular hybrids for breast cancer research and treatment
inferred← citeshttps://doi.org/10.1039/d3dt01348kopenalex-snapshot
Synthesis, characterization, photophysical and electrochemical properties, and biomolecular interaction of 2,2′-biquinoline based phototoxic Ru( ii )/Ir( ii ) complexes
inferred← citeshttps://doi.org/10.1039/d3qi00908dopenalex-snapshot
Folate-targeted iridium complexes amplify photodynamic therapy efficacy through ferroptosis
inferred← citeshttps://doi.org/10.1039/d4dt00766bopenalex-snapshot
Aqueous emissive cyclometalated iridium photoreductants: synthesis, computational analysis and the photocatalytic reduction of 4-nitrophenol
inferred← citeshttps://doi.org/10.1039/d4dt01571aopenalex-snapshot
Multi-functional biotinylated platinum( iv )–SAHA conjugate for tumor-targeted chemotherapy
inferred← citeshttps://doi.org/10.1039/d5sc07181jopenalex-snapshot
Phosphorescent iridium complexes activated by endogenous zinc as a mitochondrial DNA nuclease for stimulation of the cGAS-STING pathway
inferred← citeshttps://doi.org/10.1039/d6dt01255hopenalex-snapshot
Exploring the self-assembling ability of cyclometallated Rh( iii ) complexes with different N,N-chelating ligands in water
inferred← citeshttps://doi.org/10.1039/d6qi00422aopenalex-snapshot
Multifunctional SAHA-derived 8-hydroxyquinoline metallopharmacophores: HDAC inhibition and antiproliferative activity
inferred← citeshttps://doi.org/10.1055/a-2684-3595openalex-snapshot
Recent Development of Metallopharmaceuticals in Cancer Therapy: Ruthenium Complexes and Their Analogues
inferred← citeshttps://doi.org/10.1080/00958972.2018.1564911openalex-snapshot
Four Ni(II), Co(III), Cd(II) complexes based on 5-(pyrazol-1-yl)nicotinic acid: synthesis, X-ray single crystal structure, in vitro cytotoxicity, apoptosis and molecular docking studies
inferred← citeshttps://doi.org/10.1093/mtomcs/mfac068openalex-snapshot
Lysosome-targeted cyclometalated iridium(III) complexes: JMJD inhibition, dual induction of apoptosis, and autophagy
inferred← citeshttps://doi.org/10.1142/s0219633620500066openalex-snapshot
A theoretical study on cyclometalated iridium (III) complexes by using a density functional theory
inferred← citeshttps://doi.org/10.1186/s13148-017-0359-xopenalex-snapshot
Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of CDKN1A
inferred← citeshttps://doi.org/10.1517/17460441.2016.1135125openalex-snapshot
An overview of molecular hybrids in drug discovery
inferred← citeshttps://doi.org/10.2174/0929867325666180307112029openalex-snapshot
Mitochondria-Targeting Anticancer Metal Complexes
inferred← citeshttps://doi.org/10.3389/fchem.2020.00402openalex-snapshot
Zinc-Containing Metalloenzymes: Inhibition by Metal-Based Anticancer Agents
inferred← citeshttps://doi.org/10.3390/molecules25102383openalex-snapshot
Anticancer Ruthenium Complexes with HDAC Isoform Selectivity
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.